MGRO MustGrow Biologics Corp.
MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage and food preservation markets. It also offers TerraMG, a mustard-derived soil biopesticide technology. In addition, the company is developing TerraSante, an organic soil amendment and biofertility technology. Further, it sells biostimulants, micronutrients, nitrogen stabilizers, and foliars. Additionally, the company offers biological and regenerative agriculture solutions to support sustainable farming. The company was formerly known as Duport Capital Ltd. and changed its name to MustGrow Biologics Corp. in March 2018. MustGrow Biologics Corp. was incorporated in 2014 and is headquartered in Saskatoon, Canada.…
Industry Peers
Agricultural InputsKey Statistics
About MustGrow Biologics (CVE: MGRO)
›
MustGrow Biologics (CVE: MGRO) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Agricultural Inputs industry, part of the Basic Materials sector.
The shares were at 0.2900 CAD on 19 November 2026, down 58.0% over 52 weeks. Its 52-week range is 0.2750 CAD to 0.9400 CAD: the price is 69.1% below the high and 5.5% above the low.
Its market capitalisation is 20.42M CAD.
MustGrow Biologics reports an operating margin of -45.3% and revenue up 359.7% year over year.
It holds more cash than debt, a net cash position of 3.86M CAD. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health. The next earnings report is expected on 2 December 2026.